ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced the successful initial use of its Artificial...
Designation for BXCL701 in combination with a checkpoint inhibitor (CPI) for treatment of patients with metastatic SCNC with progression on chemotherapy and no evidence...
Oral Presentation at the 2024 SCOPE Conference Outlines Unique Technology to Orchestrate Clinical Research Trials
EDETEK Inc., a leading global provider of modern clinical...
Genialis, the RNA-biomarker company, and Debiopharm, a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases,...
ImmunoScape, a biotechnology company focused on the discovery and development of next-generation T cell receptor (TCR)-based therapeutics, and MiNK Therapeutics, Inc, a clinical stage biopharmaceutical...
ClearNote® Health, a company with a mission to enable longer lives for people with cancer through earlier detection and empowering biopharmaceutical companies in developing...
Contract Medical and Commercial Organization, Amplity Health has released a revolutionary AI-driven next best action solution that provides pharmaceutical and biopharmaceutical companies with an entirely new...